Categories: News

CENTR Brands Corp. Announces Tennessee Launch

Vancouver, British Columbia–(Newsfile Corp. – January 13, 2021) – CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) (“CENTR“) is pleased to announce the Tennessee launch of CENTR™ and new CENTR™ Sugar Free, its sweetener-free, all natural CBD beverage with just 10 calories. CENTR™ and CENTR™ Sugar Free will be distributed by Nashville-based Hempire Distributing, LLC (“Hempire”). Hempire is powered by Ajax Turner, a distributor of premium non-alcohol beverages, top-selling local, regional, and import brewers, and award-winning wines and spirits.

Hempire is a hemp, CBD, and health product DSD distribution company focused on delivering the best quality hemp-based products to retail locations across the Middle Tennessee area. Find out more by visiting Hempire’s website: https://www.hempiredistributing.com/.

“Hempire is a superb partner for CENTR in Tennessee,” said CEO Joseph Meehan. “With Ajax Turner’s distribution network and system, Hempire brings a new level of sophistication and scale we are excited to partner with.”

CENTR™ and CENTR™ Sugar Free are now available for sale in 19 U.S. states, sold to thousands of retailers and on-premise accounts via a network of 10 regional distributors.

About CENTR Brands Corp. CENTR Brands Corp. develops and markets non-alcoholic, functional “better beverages” for the global market. The Company’s first products, CENTR™ and CENTR™ Sugar Free, are sparkling, low-calorie, CBD beverages.

Follow CENTR Brands Corp. on LinkedIn, on Instagram and Facebook at @findyourcentr, and www.findyourcentr.com.

For further information, contact Joseph Meehan at jmeehan@centrcorp.com.

On behalf of the Board,

CENTR BRANDS CORP.

/s/ Joseph Meehan

Joseph Meehan, Chief Executive Officer

This press release may contain “Forward-Looking Statements” within the meaning of applicable Canadian securities laws. Actual results may differ from those indicated as a result of finalization of the Company’s financial statements as well as other risks and uncertainties. Such statements represent the Company’s current views with respect to future events and are necessarily based upon a number of assumptions and estimates that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political and social risks, contingencies and uncertainties. Many factors, both known and unknown, could cause results, performance or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements. The Company does not intend, and does not assume any obligation, to update these forward-looking statements or information to reflect changes in assumptions or changes in circumstances or any other events affecting such statements and information other than as required by applicable laws, rules and regulations.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/71864

Staff

Recent Posts

Health Care AI Initiative Launched by Paragon Health Institute

New initiative will promote AI policies and solutions to transform American health careWASHINGTON, Jan. 12,…

10 minutes ago

Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound

Agreement expands Amphastar's proprietary peptide pipeline into broader inflammatory and autoimmune conditions RANCHO CUCAMONGA, CA…

11 minutes ago

CelLBxHealth PLC Announces Board Changes

GUILDFORD, SURREY / ACCESS Newswire / January 12, 2026 / CelLBxHealth plc (AIM:CLBX), a leader…

3 hours ago

Cosmo Enters Scale Up Phase with 104M Revenue, 128M Cash, and Breakout AI and Dermatology Platforms

Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in…

4 hours ago

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

18 hours ago